“…Genes thought to be E2F targets include protooncogenes (Heibert et al, 1989;Lam and Watson, 1993), G1 cyclins (Muller et al, 1994;Henglein et al, 1994;Ohtani et al, 1995), enzymes required for DNA synthesis (Pearson et al, 1991;Means et al, 1992;Fridovich-Keil et al, 1993), and the G2-speci®c cdk, cdc2 (Dalton, 1992;Tommasi and Pfeifer, 1995). Several recent studies suggest that E2F may be primarily a negative regulator of transcription, directing the binding of repressors, such as pRb, to speci®c target genes (Tommasi and Pfeifer, 1995;Field et al, 1996;Yamasaki et al, 1996;Zwicker et al, 1996). This view is supported by the observation that mice bearing homozygous deletions of the E2F-1 gene do not have defects in cell proliferation, but rather show an increased tendency to develop tumors (Field et al, 1996;Yamasaki et al, 1996;Zwicker et al, 1996).…”